1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Middle East & Africa Pharma ADMET Testing Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Middle East & Africa Pharma ADMET Testing Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Middle East & Africa Pharma ADMET Testing Market Regional Analysis
6.2 Middle East & Africa Pharma ADMET Testing Market Revenue 2020-2028 (US$ Million)
6.3 Middle East & Africa Pharma ADMET Testing Market Forecast Analysis
7. Middle East & Africa Pharma ADMET Testing Market Analysis – by Testing Type
7.1 In Vivo ADMET Testing
- 7.1.1 Overview
- 7.1.2 In Vivo ADMET Testing: Middle East & Africa Pharma ADMET Testing Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.2 In Vitro ADMET Testing
- 7.2.1 Overview
- 7.2.2 In Vitro ADMET Testing: Middle East & Africa Pharma ADMET Testing Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.3 In Silico ADMET Testing
- 7.3.1 Overview
- 7.3.2 In Silico ADMET Testing: Middle East & Africa Pharma ADMET Testing Market – Revenue and Forecast, 2020-2028 (US$ Million)
8. Middle East & Africa Pharma ADMET Testing Market Analysis – by Technology
8.1 Cell Culture
- 8.1.1 Overview
- 8.1.2 Cell Culture: Middle East & Africa Pharma ADMET Testing Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.2 High Throughput
- 8.2.1 Overview
- 8.2.2 High Throughput: Middle East & Africa Pharma ADMET Testing Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.3 Molecular Imaging
- 8.3.1 Overview
- 8.3.2 Molecular Imaging: Middle East & Africa Pharma ADMET Testing Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.4 OMICS Technology
- 8.4.1 Overview
- 8.4.2 OMICS Technology: Middle East & Africa Pharma ADMET Testing Market – Revenue and Forecast, 2020-2028 (US$ Million)
9. Middle East & Africa Pharma ADMET Testing Market Analysis – by Application
9.1 Systemic Toxicity
- 9.1.1 Overview
- 9.1.2 Systemic Toxicity: Middle East & Africa Pharma ADMET Testing Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.2 Renal Toxicity
- 9.2.1 Overview
- 9.2.2 Renal Toxicity: Middle East & Africa Pharma ADMET Testing Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.3 Hepatotoxicity
- 9.3.1 Overview
- 9.3.2 Hepatotoxicity: Middle East & Africa Pharma ADMET Testing Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.4 Neurotoxicity
- 9.4.1 Overview
- 9.4.2 Neurotoxicity: Middle East & Africa Pharma ADMET Testing Market – Revenue and Forecast, 2020-2028 (US$ Million)
10. Middle East & Africa Pharma ADMET Testing Market – Middle East and Africa Analysis
10.1 Overview
10.2 Middle East and Africa
- 10.2.1 Middle East & Africa Pharma ADMET Testing Market Breakdown, by Key
Country, 2023 and 2028 (%)
- 10.2.1.1 Middle East & Africa Pharma ADMET Testing Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 South Africa:
Middle East & Africa Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.1.1 South Africa: Middle East & Africa Pharma ADMET Testing Market Breakdown, by Testing Type
- 10.2.1.1.2 South Africa: Middle East & Africa Pharma ADMET Testing Market Breakdown, by Technology
- 10.2.1.1.3 South Africa: Middle East & Africa Pharma ADMET Testing Market Breakdown, by Application
- 10.2.1.2 Saudi Arabia:
Middle East & Africa Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.2.1 Saudi Arabia: Middle East & Africa Pharma ADMET Testing Market Breakdown, by Testing Type
- 10.2.1.2.2 Saudi Arabia: Middle East & Africa Pharma ADMET Testing Market Breakdown, by Technology
- 10.2.1.2.3 Saudi Arabia: Middle East & Africa Pharma ADMET Testing Market Breakdown, by Application
- 10.2.1.3 UAE:
Middle East & Africa Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.3.1 UAE: Middle East & Africa Pharma ADMET Testing Market Breakdown, by Testing Type
- 10.2.1.3.2 UAE: Middle East & Africa Pharma ADMET Testing Market Breakdown, by Technology
- 10.2.1.3.3 UAE: Middle East & Africa Pharma ADMET Testing Market Breakdown, by Application
- 10.2.1.4 Rest of Middle East and Africa:
Middle East & Africa Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.4.1 Rest of Middle East and Africa: Middle East & Africa Pharma ADMET Testing Market Breakdown, by Testing Type
- 10.2.1.4.2 Rest of Middle East and Africa: Middle East & Africa Pharma ADMET Testing Market Breakdown, by Technology
- 10.2.1.4.3 Rest of Middle East and Africa: Middle East & Africa Pharma ADMET Testing Market Breakdown, by Application
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Agilent Technologies, Inc.
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Bio-Rad Laboratories, Inc.
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Biovia (Dassault Systèmes)
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Charles River Laboratories
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 IQVIA Inc.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 MERCK KGaA
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Promega Corporation
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Wuxi AppTec
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations